S4 E17, Adrienne Mendoza - Chief Operating Officer of BBG Advanced Therapies

<p><em><strong>Solving More Than Science with Adrienne Mendoza</strong></em></p><p><br></p><p>Cell and gene therapy is advancing rapidly, but science alone isn’t enough.</p><p>In this episode of <em>She Leads Biotech</em>, Adrienne Mendoza, Chief Operating Officer of BBG Advanced Therapies, shares what’s really needed to move the field forward, from improving access and infrastructure to rethinking how these therapies reach patients.</p><p>We also explore her journey over the past year, building a stronger presence in the industry, translating complex science for broader audiences, and the realities of leading through a challenging and evolving market.</p><p>A practical and honest look at where the field is today, and what it will take to get to the next stage.</p><p><br></p><p><strong>Chapters</strong></p><p>00:00 Introduction<br>02:00 Stepping into a New Role at BBG Advanced Therapies<br>05:00 How the Role of a COO Evolves<br>08:30 Building Presence and Community in CGT<br>12:00 Making Complex Science Understandable<br>16:00 The Mobile Leukapheresis Bus<br>21:00 Access Challenges in Cell &amp; Gene Therapy<br>27:00 What Needs to Change in the System<br>33:00 Industry Challenges and Optimism<br>38:00 What the Next 5 Years Could Look Like<br>41:00 Life Outside of Biotech</p><p><br></p><p>#SheLeadsBiotech #CellAndGeneTherapy #BiotechLeadership #LifeSciences #CNAUSAExecutiveSearch</p>